Design of PD-L1 inhibitors for lung cancer

The progression of lung cancer is associated with inactivation of programmed cell death protein 1, abbreviated as PD- 1 which regulates the suppression of the body's immune system by suppressing T- cell inflammatory activity and is responsible for preventing cancer cell growth. It is of interes...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Bioinformation
Asıl Yazarlar: Udhwani, Trishang, Mukherjee, Sourav, Sharma, Khushboo, Sweta, Jajoriya, Khandekar, Natasha, Nayarisseri, Anuraj, Singh, Sanjeev Kumar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Biomedical Informatics 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6677907/
https://ncbi.nlm.nih.gov/pubmed/31435160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630015139
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller